Grail announced fresh data on Friday from a large U.S. study of its flagship Galleri blood-based test for detecting dozens of ...

Research published in the journal BMJ Open in May found that an annual blood test for cancer could lead to 49 per cent fewer ...

Blood tests that detect early cancer are coming to market. Could they lead to earlier diagnosis and treatment?

The Galleri test identifies DNA in the bloodstream that has been shed by cancer cells, giving the earliest signs somebody may ...

Consumers have testing options beyond the once-a-decade colonoscopy. But some doctors question Cologuard's testing program.

Only MCED test on-market to analyze multiple biomarker classes, enhancing early cancer detection-Offered as a laboratory-developed test at ...

Cancer will claim an estimated 618,000 lives in the U.S. in 2025, according to the American Cancer Society. Yet, despite advances in treatment, most ...

The test, screening for more than 50 cancers, is being trialled across the NHS ...

Former UK prime minister Rishi Sunak has called for a targeted prostate cancer screening program for men most at high risk of ...

A genetic risk score could one day help women with DCIS or LCIS know if they are high or low risk and decide which treatment ...

A combination of genetic tests for a "very complex" blood cancer could accurately predict if the disease is likely to return ...

The entities have committed to an investment of $110m (Won156.58bn) in Grail, with the purchase price set at $70.05 per share ...